Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy: Radiopharmaceutical Therapy

Investigation of new biodegradable 32P-chromic phosphate-poly(L-lactide-co-glycolide) seed after intratumor implantation

Guo-qiang Shao, Zi-zheng Wang, Feng Wang, Shao-hua Li and Yan Huang
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1734;
Guo-qiang Shao
1Nuclear Medicine, Nanjing Medical University, Affiliated Nanjing First Hospital, Nanjing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zi-zheng Wang
1Nuclear Medicine, Nanjing Medical University, Affiliated Nanjing First Hospital, Nanjing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Feng Wang
1Nuclear Medicine, Nanjing Medical University, Affiliated Nanjing First Hospital, Nanjing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shao-hua Li
1Nuclear Medicine, Nanjing Medical University, Affiliated Nanjing First Hospital, Nanjing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yan Huang
1Nuclear Medicine, Nanjing Medical University, Affiliated Nanjing First Hospital, Nanjing, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

1734

Objectives 32P-chromic phosphate-poly(L-lactide-co-glycolide) (32P-CP-PLGA),with biodegradable, compatible PLGA(75/25) as control release carrier for 32P-CP particles, is a new seed for brachytherapy of deep seated tumors. The objective of this study was to investigate its physico-chemical property, dynamic structure changes and systemic distribution of 32P-CP particles in tumor-bearing mice after interstitial administration.

Methods 32P-CP-PLGA seeds were prepared via continue co-adhesion and encapsulation of 32P-CP particles by micronized PLGA(75/25,Mo:10000). Tumor models (H22, Balb/c) were assigned randomly into two groups. 32P-CP-PLGA seeds (seeds group, SG) and 32P-CP colloids (colloids group, CG), with radioactivity of 9.25MBq, were adminitrated to the tumor core. SPECT planar imaging was acquired and %ID/g of different organs, radioactivity of residual seeds were calculated after their sacrifice every 3 days. Scaning electron examination was carried out to observe ultrastructure changes of the seed.

Results 32P-CP-PLGA seeds were cylindrical with hardness, apparent radioactivity of (4.5±1.1) N, (9.25±1.85) MBq. The peak %ID/g of the liver, spleen and bone in SG were 1.056%, 0.934% and 0.616%, lower than that in CG (3.528%, 4.115%, 2.127%, P1, P2, P3<0.05). SPECT planar images demonstrate punctiform appearance of 32P in SG and irregular appearance with abnormal liver, spleen visualization in CG. The intratumor effective half-life of 32P was about 12.2d in SG and 9.4d in CG. Swollen volume, increasing number of micropores, tunnels in seeds, existence of released 32P-CP particles adjacent to seeds in the tumor were observed.

Conclusions Biodegradable 32P-CP-PLGA seeds, enjoying higher local dose radiation and longer intratumoral effective half-life than 32P-CP colloid, may hold promise for deep seated tumor brachytherapy.

Research Support National Natural Science Foundation of China(No.81071185

Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Investigation of new biodegradable 32P-chromic phosphate-poly(L-lactide-co-glycolide) seed after intratumor implantation
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Investigation of new biodegradable 32P-chromic phosphate-poly(L-lactide-co-glycolide) seed after intratumor implantation
Guo-qiang Shao, Zi-zheng Wang, Feng Wang, Shao-hua Li, Yan Huang
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1734;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Investigation of new biodegradable 32P-chromic phosphate-poly(L-lactide-co-glycolide) seed after intratumor implantation
Guo-qiang Shao, Zi-zheng Wang, Feng Wang, Shao-hua Li, Yan Huang
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 1734;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy: Radiopharmaceutical Therapy

  • Characterization of 177Lu-Affibody-HSA bioconjugate for radionuclide therapy of EGFR-expressing head and neck carcinomas
  • Low-dose hyper-radiosensitivity model for 131I radioimmunotherapy of non-Hodgkin’s lymphoma
  • Monitoring the correlation between I-uptake and apoptosis using Apoptosis-targeting peptide-1 (ApoPep-1)
Show more Oncology: Basic, Translational & Therapy: Radiopharmaceutical Therapy

Radiopharmaceutical Therapy Posters

  • Development of a thermosensitive hydrogel system for local delivery of radionuclide and chemotherapeutic drug in a hepatocellular carcinoma
  • Preclinical evaluation of Sm-153-DOTMP as a therapeutic bone-seeking radiopharmaceutical
  • Low-dose hyper-radiosensitivity model for 131I radioimmunotherapy of non-Hodgkin’s lymphoma
Show more Radiopharmaceutical Therapy Posters

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire